Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
Orforglipron: Bloodwork Guide
Recommended lab tests and biomarkers to monitor before, during, and after Orforglipron therapy. Testing schedules are based on clinical protocols and published monitoring guidelines.
Back to Orforglipron overviewBefore Starting (2 tests)
| Biomarker | Expected Effect | Retest |
|---|---|---|
| ALT/AST | → normalizes | Every 12 weeks |
| Lipid Panel | → normalizes | Every 24 weeks |
During Treatment (3 tests)
| Biomarker | Expected Effect | Retest |
|---|---|---|
| HbA1c | ↓ decreases | Every 12 weeks |
| Fasting Glucose | ↓ decreases | Every 4 weeks |
| Body Weight | ↓ decreases | Every 4 weeks |